Fecal transplant for IBS with diarrhea and anxiety or depression
Treatments studied
Part of Digestive system, Mental health clinical trials.
This trial tests if a fecal microbiota transplant (FMT) can help young adults with irritable bowel syndrome with diarrhea (IBS-D) who also have symptoms of anxiety or depression. FMT involves putting processed stool from a healthy donor into your gut to improve digestive and mental health at the same time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 29 years old.
- You have IBS with diarrhea (loose, urgent stools) most of the time for at least 3 months, and belly pain at least once a week.
- You also have symptoms of depression or anxiety that affect you moderately.
- You have had a colonoscopy in the last year that was either normal or showed only minor issues like small polyps (removed if needed).
- You are willing to stop taking certain gut-related medicines (like antibiotics, antidiarrheals, or probiotics) for 2 weeks before starting and during the trial.
- You are willing to keep your usual diet, lifestyle, and birth control methods stable during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether transferring stool bacteria from a healthy donor (fecal microbiota transplantation) can improve symptoms of irritable bowel syndrome (IBS). It may help by changing the gut bacteria that can influence digestion and gut discomfort.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
This study tests whether transferring gut bacteria from a healthy donor to a participant can reduce irritable bowel syndrome (IBS) symptoms related to food sensitivity. You may be asked to follow a low-FODMAP diet and receive a fecal microbiota transplant if you meet the study’s safety and health requirements.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This study tests whether fecal microbiota transplantation (a stool-based treatment to change gut bacteria) can reduce symptoms of irritable bowel syndrome (IBS) that comes with diarrhea. You may be eligible if you’re an adult with diarrhea-predominant IBS and recent colonoscopy results that rule out other intestinal diseases.
This study tests whether a fecal microbiota transplant (FMT) — transferring healthy stool bacteria into your gut — can help people with severe irritable bowel syndrome (IBS) that hasn't improved after trying at least two other treatments.
Hear when a new Irritable Bowel Syndrome - Diarrhoea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.